You have no items in your shopping cart.
Human FGFRL1 [orb2995021]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.9 KDa. Observed: 65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human TWEAK R [orb2993998]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.7 KDa. Observed: 30-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF R3 [orb2994172]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39 KDa. Observed: 60-75 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse TWEAK R [orb2993966]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.6 KDa. Observed: 30-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF R3 [orb2994760]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 64.8 KDa. Observed: 95-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Rat FGFR4 [orb2992573]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 65.8 KDa. Observed: 80-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human FGFR2 beta [orb2993025]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.2 KDa. Observed: 72-95 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFR2IIIb [orb2993041]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 66.5 KDa. Observed: 85-120 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human FGFR2IIIb [orb2993042]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 26.2 KDa. Observed: 40-70 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFR2IIIc [orb2993043]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 66.5 KDa. Observed: 85-120 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg